Active Ingredient (In Each Tablet)
Omeprazole 20 mg
The following Structured Product Label (SPL) was submitted to the FDA by Padagis Israel Pharmaceuticals Ltd for the product Omeprazole (NDC 45802-888). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, use, warnings, do not use if you have:, ask a doctor before use if you have:, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Omeprazole 20 mg
Acid reducer
Allergy alert:
If an allergic reaction occurs, stop use and seek medical help right away.
These may be signs of a serious condition. See your doctor.
taking a prescription drug. Acid reducers may interact with certain prescription drugs.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate
Compare to Prilosec OTC®
Omeprazole Delayed Release Tablets 20 mg
Acid Reducer
Actual Size
24HR
42 Tablets
Three 14-day courses of treatment
May take 1 to 4 days for full effect
Treats Frequent Heartburn!
Padagis®
* Please review the disclaimer below.